The downgrade is based on a number of factors, including SPH’s elevated risk of debt acceleration, marked decline in financial performance and vulnerability as a small provider with close proximity to larger systems in Madison, Wis.
The outlook is negative, reflecting Moody’s Investors Service’s expectation that SPH will continue to experience financial pressure in the near term.
More articles on healthcare finance:
Charity care declines by 50% at Wisconsin hospitals
Amid Illinois budget crisis, Springfield Clinic will bill patients for back payments
6 of 10 S&P worst-performing stocks in healthcare
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
